Researchers: Cannabinoids Provide Modest Analgesic Benefit for Central Neuropathic Pain

San Diego—Those touting the panacea-like properties of cannabinoids may be disappointed by a recent study from Canada. The systematic review and meta-analysis of trials for chronic neuropathic pain has shown that cannabinoids provide only a modest analgesic benefit compared with conventional management or placebo.

According to the study’s authors, the moderate quality of evidence suggested that cannabinoids are effective in reducing central but not peripheral neuropathic pain.